Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we me...
Saved in:
Published in | Journal of lipid research Vol. 63; no. 9; p. 100263 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2022
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African American (AA), Chinese American (CA), and Hispanic American (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanic American (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids. |
---|---|
AbstractList | Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids. Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African American (AA), Chinese American (CA), and Hispanic American (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanic American (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids. Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids. |
ArticleNumber | 100263 |
Author | Koska, Juraj Hu, Yueming McClelland, Robyn L. Reaven, Peter Nedelkov, Dobrin Furtado, Jeremy Billheimer, Dean Budoff, Matthew J. Sinari, Shripad |
Author_xml | – sequence: 1 givenname: Juraj orcidid: 0000-0002-6671-6250 surname: Koska fullname: Koska, Juraj email: juraj.koska@va.gov organization: Phoenix VA Health Care System, Phoenix, AZ, USA – sequence: 2 givenname: Jeremy surname: Furtado fullname: Furtado, Jeremy organization: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA – sequence: 3 givenname: Yueming surname: Hu fullname: Hu, Yueming organization: Isoformix Inc, Phoenix, AZ, USA – sequence: 4 givenname: Shripad surname: Sinari fullname: Sinari, Shripad organization: Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA – sequence: 5 givenname: Matthew J. surname: Budoff fullname: Budoff, Matthew J. organization: Los Angeles Biomedical Research Institute, Torrance, CA, USA – sequence: 6 givenname: Dean surname: Billheimer fullname: Billheimer, Dean organization: Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA – sequence: 7 givenname: Dobrin surname: Nedelkov fullname: Nedelkov, Dobrin organization: Isoformix Inc, Phoenix, AZ, USA – sequence: 8 givenname: Robyn L. surname: McClelland fullname: McClelland, Robyn L. organization: Department of Biostatistics, University of Washington, Seattle, WA, USA – sequence: 9 givenname: Peter surname: Reaven fullname: Reaven, Peter organization: College of Health Solutions, Arizona State University, Phoenix, AZ, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35952903$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1v1DAUtFAR3RZ-ABfkI5cstvPhWJyqVYGVikACzpbjD_ZFSRxsp6hH_jlOU3rgUFnye36eGVszF-hs8pNF6DUle0po867f90PYM8JYPhPWlM_QjtalKDhr2Bna5RkrGOP1ObqIsSeEVlVDX6DzshY1E6TcoT9fBxVHhefgk_XOhzFi77Ca_QCzv5_CFPGhOGI1mbXmJlisYvQaVLIG_4Z0wvMmk0lgIoYJp5PFn5chQXGdThNo_C0t5m7VvspXwUc9rDvEl-i5U0O0rx7qJfrx4fr74VNx8-Xj8XB1U-iqYangrRbU2JbrjhpXu7p1utH1uhQRxFYVLYnTylDKuGgbU6u21NRoK6rsgyov0XHTNV71cg4wqnAnvQJ5P_Dhp1QhQf6WJNrxRlSmYazLul3LHae846RlghFLs9bbTSsb9GuxMckRorbDoCbrlygZJ4yKKtudoW8eoEs3WvP48L8IMoBuAJ3tiMG6Rwglco1Z9jLHLNeY5RZz5vD_OBqSSuCnFBQMTzLfb0ybrb4FG2TUYCdtDQSrU_YCnmD_BTKtwQ4 |
CitedBy_id | crossref_primary_10_3390_biomedicines12102403 crossref_primary_10_1371_journal_pone_0282821 crossref_primary_10_1016_j_atherosclerosis_2023_117214 crossref_primary_10_1371_journal_pone_0313625 crossref_primary_10_2337_dc24_1462 |
Cites_doi | 10.1016/S0021-9258(18)67554-4 10.1161/CIRCRESAHA.113.300634 10.1074/jbc.M203151200 10.1194/jlr.P064816 10.1074/jbc.M113.495366 10.1194/jlr.M800588-JLR200 10.1016/j.metabol.2011.12.002 10.2337/db11-0040 10.1194/jlr.D071787 10.1016/0026-0495(79)90004-0 10.1016/0006-2944(79)90063-2 10.1016/S0021-9258(18)32773-X 10.1210/er.2014-1035 10.1097/MOL.0000000000000680 10.1001/archinte.165.12.1395 10.1161/01.CIR.0000157730.94423.4B 10.1194/jlr.M400301-JLR200 10.1093/aje/kwf113 10.1080/713609354 10.3390/ijms20235939 10.1161/01.ATV.19.3.472 10.1161/CIRCULATIONAHA.106.622514 10.1097/00041433-200106000-00009 10.1073/pnas.80.9.2574 10.1515/cclm-2017-1099 10.1006/pmed.2002.1045 10.1016/j.atherosclerosis.2017.10.025 10.1093/clinchem/18.6.499 10.1161/ATVBAHA.117.307025 10.1016/0006-291X(70)90468-7 10.3945/jn.116.242750 10.1194/jlr.P064170 10.1016/0009-8981(75)90374-5 10.1161/01.ATV.3.3.260 10.1093/clinchem/27.4.543 10.1161/ATVBAHA.107.160192 10.1111/eci.12657 10.1016/S0022-2275(20)32459-7 10.1161/ATVBAHA.109.197830 10.1007/s13300-015-0123-1 |
ContentType | Journal Article |
Copyright | 2022 The Authors Published by Elsevier Inc. |
Copyright_xml | – notice: 2022 The Authors – notice: Published by Elsevier Inc. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/j.jlr.2022.100263 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1539-7262 |
ExternalDocumentID | oai_doaj_org_article_0cf7694d622b441b87f717b7082920e1 35952903 10_1016_j_jlr_2022_100263 S0022227522000967 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL138969 |
GroupedDBID | --- -~X .55 .GJ 0SF 0VX 18M 29K 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. AAEDW AAFTH AAFWJ AAXUO AAYOK ABCQX ABOCM ACCCW ACGFO ACKIV ACNCT ACPRK ADBBV AENEX AEXQZ AFFNX AFOSN AFPKN AHPSJ AI. ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CS3 D-I DIK DU5 E3Z EBS EJD F5P FDB FRP GROUPED_DOAJ GX1 H13 HH5 HYE H~9 J5H KQ8 L7B MVM OK1 P2P RHF RHI ROL RPM TBC TR2 TWZ VH1 W8F WH7 WOQ X7M XFK YHG YKV ZA5 ZGI ZXP ~KM 0R~ AALRI AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AITUG AKBMS AKRWK AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c462t-78c91de87cb1df5f58fc6c5c5c5a090e44130fcad1127986d5a83c1dce94002a3 |
IEDL.DBID | DOA |
ISSN | 0022-2275 1539-7262 |
IngestDate | Wed Aug 27 01:29:42 EDT 2025 Fri Jul 11 04:40:02 EDT 2025 Thu Jan 02 22:52:06 EST 2025 Tue Jul 01 01:31:52 EDT 2025 Thu Apr 24 23:01:00 EDT 2025 Fri Feb 23 02:40:39 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | atherosclerosis AA MESA proteomics lipid metabolism lipid transport DPP-4 LPL triglycerides race/ethnicity TRL HDL GFR cholesterol mass spectrometry apolipoprotein posttranslational proteoforms apoC-I apoC-II CA |
Language | English |
License | This is an open access article under the CC BY license. Published by Elsevier Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-78c91de87cb1df5f58fc6c5c5c5a090e44130fcad1127986d5a83c1dce94002a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6671-6250 |
OpenAccessLink | https://doaj.org/article/0cf7694d622b441b87f717b7082920e1 |
PMID | 35952903 |
PQID | 2702194144 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0cf7694d622b441b87f717b7082920e1 proquest_miscellaneous_2702194144 pubmed_primary_35952903 crossref_primary_10_1016_j_jlr_2022_100263 crossref_citationtrail_10_1016_j_jlr_2022_100263 elsevier_sciencedirect_doi_10_1016_j_jlr_2022_100263 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-00 20220901 2022-09-01 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of lipid research |
PublicationTitleAlternate | J Lipid Res |
PublicationYear | 2022 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Sumner, Finley, Genovese, Criqui, Boston (bib24) 2005; 165 Abbott, Garrison, Wilson, Epstein, Castelli, Feinleib (bib25) 1983; 3 Larsson, Vorrsjo, Talmud, Lookene, Olivecrona (bib27) 2013; 288 Reimund, Kovrov, Olivecrona, Lookene (bib37) 2017; 58 Zannis, Karathanasis, Keutmann, Goldberger, Breslow (bib39) 1983; 80 Wolska, Dunbar, Freeman, Ueda, Amar, Sviridov (bib2) 2017; 267 Adiels, Olofsson, Taskinen, Boren (bib35) 2008; 28 Mendivil, Zheng, Furtado, Lel, Sacks (bib18) 2010; 30 Olivieri, Chiariello, Martinelli, Castagna, Speziali, Girelli (bib15) 2018; 56 Curry, McConathy, Fesmire, Alaupovic (bib29) 1981; 27 Cyr, Wassef, Bissonnette, Lamantia, Davignon, Faraj (bib23) 2016; 57 Gerber, Goldbourt, Cohen, Harats (bib32) 2002; 35 Koska, Yassine, Trenchevska, Sinari, Schwenke, Yen (bib14) 2016; 57 Bild, Detrano, Peterson, Guerci, Liu, Shahar (bib17) 2005; 111 Schonfeld, George, Miller, Reilly, Witztum (bib33) 1979; 28 Lambeir, Durinx, Scharpe, De Meester (bib12) 2003; 40 Kawakami, Aikawa, Alcaide, Luscinskas, Libby, Sacks (bib42) 2006; 114 Mulvihill, Drucker (bib13) 2014; 35 Bild, Bluemke, Burke, Detrano, Diez Roux, Folsom (bib16) 2002; 156 LaRosa, Levy, Herbert, Lux, Fredrickson (bib6) 1970; 41 Kei, Filippatos, Tsimihodimos, Elisaf (bib8) 2012; 61 Sorensen, Sondergaard, Nellemann, Christiansen, Gormsen, Nielsen (bib34) 2011; 60 Gordon, Sims, Lentz, Edelstein, Scanu, Strauss (bib38) 1983; 258 Sacks, Jensen (bib40) 2018; 38 Ekman, Nilsson-Ehle (bib28) 1975; 63 de Barros, Boualam, Gautier, Dumont, Verges, Masson (bib30) 2009; 50 Bondarenko, Cockrill, Watkins, Cruzado, Macfarlane (bib9) 1999; 40 Shachter (bib3) 2001; 12 Jong, Hofker, Havekes (bib4) 1999; 19 Friedewald, Levy, Fredrickson (bib19) 1972; 18 Fojo, Taam, Fairwell, Ronan, Bishop, Meng (bib11) 1986; 261 Wolska, Reimund, Remaley (bib7) 2020; 31 Oldoni, Sinke, Kuivenhoven (bib41) 2014; 114 Hansen, Fernandez, Noto, Deguchi, Bjorkegren, Mathiesen (bib21) 2011; 2011 Wassef, Bissonnette, Dufour, Davignon, Faraj (bib22) 2017; 147 Gautier, Masson, Jong, Duverneuil, Le Guern, Deckert (bib31) 2002; 277 Fuior, Gafencu (bib1) 2019; 20 Havel, Kotite, Kane (bib5) 1979; 21 Berbee, van der Hoogt, Sundararaman, Havekes, Rensen (bib26) 2005; 46 Hu, Meuret, Martinez, Yassine, Nedelkov (bib10) 2020; 62 Skinner, Wroblewski, Kirihara, Nelsestuen, Seaquist (bib20) 2015; 6 Ooi, Chan, Hodson, Adiels, Boren, Karpe (bib36) 2016; 46 Jong (10.1016/j.jlr.2022.100263_bib4) 1999; 19 Abbott (10.1016/j.jlr.2022.100263_bib25) 1983; 3 Wassef (10.1016/j.jlr.2022.100263_bib22) 2017; 147 Schonfeld (10.1016/j.jlr.2022.100263_bib33) 1979; 28 Larsson (10.1016/j.jlr.2022.100263_bib27) 2013; 288 Gordon (10.1016/j.jlr.2022.100263_bib38) 1983; 258 Olivieri (10.1016/j.jlr.2022.100263_bib15) 2018; 56 Bild (10.1016/j.jlr.2022.100263_bib16) 2002; 156 Skinner (10.1016/j.jlr.2022.100263_bib20) 2015; 6 Sumner (10.1016/j.jlr.2022.100263_bib24) 2005; 165 Cyr (10.1016/j.jlr.2022.100263_bib23) 2016; 57 Friedewald (10.1016/j.jlr.2022.100263_bib19) 1972; 18 Sacks (10.1016/j.jlr.2022.100263_bib40) 2018; 38 Wolska (10.1016/j.jlr.2022.100263_bib2) 2017; 267 Reimund (10.1016/j.jlr.2022.100263_bib37) 2017; 58 de Barros (10.1016/j.jlr.2022.100263_bib30) 2009; 50 Oldoni (10.1016/j.jlr.2022.100263_bib41) 2014; 114 Lambeir (10.1016/j.jlr.2022.100263_bib12) 2003; 40 Berbee (10.1016/j.jlr.2022.100263_bib26) 2005; 46 Ekman (10.1016/j.jlr.2022.100263_bib28) 1975; 63 Adiels (10.1016/j.jlr.2022.100263_bib35) 2008; 28 Hu (10.1016/j.jlr.2022.100263_bib10) 2020; 62 Koska (10.1016/j.jlr.2022.100263_bib14) 2016; 57 Mendivil (10.1016/j.jlr.2022.100263_bib18) 2010; 30 Zannis (10.1016/j.jlr.2022.100263_bib39) 1983; 80 Mulvihill (10.1016/j.jlr.2022.100263_bib13) 2014; 35 Ooi (10.1016/j.jlr.2022.100263_bib36) 2016; 46 Fuior (10.1016/j.jlr.2022.100263_bib1) 2019; 20 Kei (10.1016/j.jlr.2022.100263_bib8) 2012; 61 Bild (10.1016/j.jlr.2022.100263_bib17) 2005; 111 Havel (10.1016/j.jlr.2022.100263_bib5) 1979; 21 LaRosa (10.1016/j.jlr.2022.100263_bib6) 1970; 41 Gautier (10.1016/j.jlr.2022.100263_bib31) 2002; 277 Kawakami (10.1016/j.jlr.2022.100263_bib42) 2006; 114 Wolska (10.1016/j.jlr.2022.100263_bib7) 2020; 31 Sorensen (10.1016/j.jlr.2022.100263_bib34) 2011; 60 Curry (10.1016/j.jlr.2022.100263_bib29) 1981; 27 Bondarenko (10.1016/j.jlr.2022.100263_bib9) 1999; 40 Hansen (10.1016/j.jlr.2022.100263_bib21) 2011; 2011 Fojo (10.1016/j.jlr.2022.100263_bib11) 1986; 261 Gerber (10.1016/j.jlr.2022.100263_bib32) 2002; 35 Shachter (10.1016/j.jlr.2022.100263_bib3) 2001; 12 |
References_xml | – volume: 35 start-page: 992 year: 2014 end-page: 1019 ident: bib13 article-title: Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors publication-title: Endocr. Rev. – volume: 21 start-page: 121 year: 1979 end-page: 138 ident: bib5 article-title: Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma publication-title: Biochem. Med. – volume: 267 start-page: 49 year: 2017 end-page: 60 ident: bib2 article-title: Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism publication-title: Atherosclerosis – volume: 12 start-page: 297 year: 2001 end-page: 304 ident: bib3 article-title: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism publication-title: Curr. Opin. Lipidol. – volume: 288 start-page: 33997 year: 2013 end-page: 34008 ident: bib27 article-title: Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets publication-title: J. Biol. Chem. – volume: 40 start-page: 209 year: 2003 end-page: 294 ident: bib12 article-title: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV publication-title: Crit. Rev. Clin. Lab. Sci. – volume: 28 start-page: 1225 year: 2008 end-page: 1236 ident: bib35 article-title: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 56 start-page: 1542 year: 2018 end-page: 1550 ident: bib15 article-title: Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease publication-title: Clin. Chem. Lab. Med. – volume: 61 start-page: 906 year: 2012 end-page: 921 ident: bib8 article-title: A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease publication-title: Metabolism – volume: 40 start-page: 543 year: 1999 end-page: 555 ident: bib9 article-title: Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein publication-title: J. Lipid Res. – volume: 165 start-page: 1395 year: 2005 end-page: 1400 ident: bib24 article-title: Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans publication-title: Arch. Intern. Med. – volume: 6 start-page: 395 year: 2015 end-page: 401 ident: bib20 article-title: Sitagliptin results in a decrease of truncated apolipoprotein C1 publication-title: Diabetes Ther. – volume: 3 start-page: 260 year: 1983 end-page: 272 ident: bib25 article-title: Joint distribution of lipoprotein cholesterol classes. The Framingham study publication-title: Arteriosclerosis – volume: 30 start-page: 239 year: 2010 end-page: 245 ident: bib18 article-title: Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 147 start-page: 754 year: 2017 end-page: 762 ident: bib22 article-title: Enrichment of triglyceride-rich lipoproteins with apolipoprotein C-I is positively associated with their delayed plasma clearance independently of other transferable apolipoproteins in postmenopausal overweight and obese women publication-title: J. Nutr. – volume: 50 start-page: 1842 year: 2009 end-page: 1851 ident: bib30 article-title: Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma publication-title: J. Lipid Res. – volume: 58 start-page: 279 year: 2017 end-page: 288 ident: bib37 article-title: Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry publication-title: J. Lipid Res. – volume: 46 start-page: 297 year: 2005 end-page: 306 ident: bib26 article-title: Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL publication-title: J. Lipid Res. – volume: 57 start-page: 1074 year: 2016 end-page: 1085 ident: bib23 article-title: WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects publication-title: J. Lipid Res. – volume: 63 start-page: 29 year: 1975 end-page: 35 ident: bib28 article-title: Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue publication-title: Clin. Chim. Acta – volume: 60 start-page: 2257 year: 2011 end-page: 2264 ident: bib34 article-title: Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men publication-title: Diabetes – volume: 19 start-page: 472 year: 1999 end-page: 484 ident: bib4 article-title: Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3 publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 27 start-page: 543 year: 1981 end-page: 548 ident: bib29 article-title: Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays publication-title: Clin. Chem. – volume: 18 start-page: 499 year: 1972 end-page: 502 ident: bib19 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin. Chem. – volume: 57 start-page: 894 year: 2016 end-page: 905 ident: bib14 article-title: Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes publication-title: J. Lipid Res. – volume: 38 start-page: 487 year: 2018 end-page: 499 ident: bib40 article-title: From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 62 year: 2020 ident: bib10 article-title: Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease publication-title: J. Lipid Res. – volume: 156 start-page: 871 year: 2002 end-page: 881 ident: bib16 article-title: Multi-ethnic study of atherosclerosis: objectives and design publication-title: Am. J. Epidemiol. – volume: 114 start-page: 124 year: 2014 end-page: 142 ident: bib41 article-title: Mendelian disorders of high-density lipoprotein metabolism publication-title: Circ. Res. – volume: 20 start-page: 5939 year: 2019 ident: bib1 article-title: Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond publication-title: Int. J. Mol. Sci. – volume: 258 start-page: 4037 year: 1983 end-page: 4044 ident: bib38 article-title: Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease publication-title: J. Biol. Chem. – volume: 35 start-page: 42 year: 2002 end-page: 47 ident: bib32 article-title: Association between serum apolipoprotein C(II) concentration and coronary heart disease publication-title: Prev. Med. – volume: 41 start-page: 57 year: 1970 end-page: 62 ident: bib6 article-title: A specific apoprotein activator for lipoprotein lipase publication-title: Biochem. Biophys. Res. Commun. – volume: 261 start-page: 9591 year: 1986 end-page: 9594 ident: bib11 article-title: Human preproapolipoprotein C-II. Analysis of major plasma isoforms publication-title: J. Biol. Chem. – volume: 111 start-page: 1313 year: 2005 end-page: 1320 ident: bib17 article-title: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation – volume: 46 start-page: 730 year: 2016 end-page: 736 ident: bib36 article-title: Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III publication-title: Eur. J. Clin. Invest. – volume: 80 start-page: 2574 year: 1983 end-page: 2578 ident: bib39 article-title: Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 114 start-page: 681 year: 2006 end-page: 687 ident: bib42 article-title: Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells publication-title: Circulation – volume: 2011 year: 2011 ident: bib21 article-title: The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis publication-title: J. Lipids – volume: 277 start-page: 31354 year: 2002 end-page: 31363 ident: bib31 article-title: Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice publication-title: J. Biol. Chem. – volume: 28 start-page: 1001 year: 1979 end-page: 1010 ident: bib33 article-title: Apolipoprotein C-II and C-III levels in hyperlipoproteinemia publication-title: Metabolism – volume: 31 start-page: 147 year: 2020 end-page: 153 ident: bib7 article-title: Apolipoprotein C-II: the re-emergence of a forgotten factor publication-title: Curr. Opin. Lipidol. – volume: 261 start-page: 9591 year: 1986 ident: 10.1016/j.jlr.2022.100263_bib11 article-title: Human preproapolipoprotein C-II. Analysis of major plasma isoforms publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)67554-4 – volume: 114 start-page: 124 year: 2014 ident: 10.1016/j.jlr.2022.100263_bib41 article-title: Mendelian disorders of high-density lipoprotein metabolism publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.113.300634 – volume: 277 start-page: 31354 year: 2002 ident: 10.1016/j.jlr.2022.100263_bib31 article-title: Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.M203151200 – volume: 57 start-page: 894 year: 2016 ident: 10.1016/j.jlr.2022.100263_bib14 article-title: Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes publication-title: J. Lipid Res. doi: 10.1194/jlr.P064816 – volume: 288 start-page: 33997 year: 2013 ident: 10.1016/j.jlr.2022.100263_bib27 article-title: Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.495366 – volume: 2011 year: 2011 ident: 10.1016/j.jlr.2022.100263_bib21 article-title: The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis publication-title: J. Lipids – volume: 50 start-page: 1842 year: 2009 ident: 10.1016/j.jlr.2022.100263_bib30 article-title: Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma publication-title: J. Lipid Res. doi: 10.1194/jlr.M800588-JLR200 – volume: 61 start-page: 906 year: 2012 ident: 10.1016/j.jlr.2022.100263_bib8 article-title: A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease publication-title: Metabolism doi: 10.1016/j.metabol.2011.12.002 – volume: 60 start-page: 2257 year: 2011 ident: 10.1016/j.jlr.2022.100263_bib34 article-title: Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men publication-title: Diabetes doi: 10.2337/db11-0040 – volume: 58 start-page: 279 year: 2017 ident: 10.1016/j.jlr.2022.100263_bib37 article-title: Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry publication-title: J. Lipid Res. doi: 10.1194/jlr.D071787 – volume: 28 start-page: 1001 year: 1979 ident: 10.1016/j.jlr.2022.100263_bib33 article-title: Apolipoprotein C-II and C-III levels in hyperlipoproteinemia publication-title: Metabolism doi: 10.1016/0026-0495(79)90004-0 – volume: 21 start-page: 121 year: 1979 ident: 10.1016/j.jlr.2022.100263_bib5 article-title: Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma publication-title: Biochem. Med. doi: 10.1016/0006-2944(79)90063-2 – volume: 258 start-page: 4037 year: 1983 ident: 10.1016/j.jlr.2022.100263_bib38 article-title: Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)32773-X – volume: 35 start-page: 992 year: 2014 ident: 10.1016/j.jlr.2022.100263_bib13 article-title: Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors publication-title: Endocr. Rev. doi: 10.1210/er.2014-1035 – volume: 31 start-page: 147 year: 2020 ident: 10.1016/j.jlr.2022.100263_bib7 article-title: Apolipoprotein C-II: the re-emergence of a forgotten factor publication-title: Curr. Opin. Lipidol. doi: 10.1097/MOL.0000000000000680 – volume: 165 start-page: 1395 year: 2005 ident: 10.1016/j.jlr.2022.100263_bib24 article-title: Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans publication-title: Arch. Intern. Med. doi: 10.1001/archinte.165.12.1395 – volume: 111 start-page: 1313 year: 2005 ident: 10.1016/j.jlr.2022.100263_bib17 article-title: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation doi: 10.1161/01.CIR.0000157730.94423.4B – volume: 46 start-page: 297 year: 2005 ident: 10.1016/j.jlr.2022.100263_bib26 article-title: Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL publication-title: J. Lipid Res. doi: 10.1194/jlr.M400301-JLR200 – volume: 156 start-page: 871 year: 2002 ident: 10.1016/j.jlr.2022.100263_bib16 article-title: Multi-ethnic study of atherosclerosis: objectives and design publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwf113 – volume: 40 start-page: 209 year: 2003 ident: 10.1016/j.jlr.2022.100263_bib12 article-title: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV publication-title: Crit. Rev. Clin. Lab. Sci. doi: 10.1080/713609354 – volume: 20 start-page: 5939 year: 2019 ident: 10.1016/j.jlr.2022.100263_bib1 article-title: Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20235939 – volume: 19 start-page: 472 year: 1999 ident: 10.1016/j.jlr.2022.100263_bib4 article-title: Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.19.3.472 – volume: 114 start-page: 681 year: 2006 ident: 10.1016/j.jlr.2022.100263_bib42 article-title: Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.622514 – volume: 12 start-page: 297 year: 2001 ident: 10.1016/j.jlr.2022.100263_bib3 article-title: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism publication-title: Curr. Opin. Lipidol. doi: 10.1097/00041433-200106000-00009 – volume: 80 start-page: 2574 year: 1983 ident: 10.1016/j.jlr.2022.100263_bib39 article-title: Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.80.9.2574 – volume: 56 start-page: 1542 year: 2018 ident: 10.1016/j.jlr.2022.100263_bib15 article-title: Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm-2017-1099 – volume: 35 start-page: 42 year: 2002 ident: 10.1016/j.jlr.2022.100263_bib32 article-title: Association between serum apolipoprotein C(II) concentration and coronary heart disease publication-title: Prev. Med. doi: 10.1006/pmed.2002.1045 – volume: 267 start-page: 49 year: 2017 ident: 10.1016/j.jlr.2022.100263_bib2 article-title: Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.10.025 – volume: 18 start-page: 499 year: 1972 ident: 10.1016/j.jlr.2022.100263_bib19 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin. Chem. doi: 10.1093/clinchem/18.6.499 – volume: 38 start-page: 487 year: 2018 ident: 10.1016/j.jlr.2022.100263_bib40 article-title: From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.117.307025 – volume: 41 start-page: 57 year: 1970 ident: 10.1016/j.jlr.2022.100263_bib6 article-title: A specific apoprotein activator for lipoprotein lipase publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(70)90468-7 – volume: 147 start-page: 754 year: 2017 ident: 10.1016/j.jlr.2022.100263_bib22 article-title: Enrichment of triglyceride-rich lipoproteins with apolipoprotein C-I is positively associated with their delayed plasma clearance independently of other transferable apolipoproteins in postmenopausal overweight and obese women publication-title: J. Nutr. doi: 10.3945/jn.116.242750 – volume: 57 start-page: 1074 year: 2016 ident: 10.1016/j.jlr.2022.100263_bib23 article-title: WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects publication-title: J. Lipid Res. doi: 10.1194/jlr.P064170 – volume: 63 start-page: 29 year: 1975 ident: 10.1016/j.jlr.2022.100263_bib28 article-title: Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(75)90374-5 – volume: 3 start-page: 260 year: 1983 ident: 10.1016/j.jlr.2022.100263_bib25 article-title: Joint distribution of lipoprotein cholesterol classes. The Framingham study publication-title: Arteriosclerosis doi: 10.1161/01.ATV.3.3.260 – volume: 27 start-page: 543 year: 1981 ident: 10.1016/j.jlr.2022.100263_bib29 article-title: Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays publication-title: Clin. Chem. doi: 10.1093/clinchem/27.4.543 – volume: 28 start-page: 1225 year: 2008 ident: 10.1016/j.jlr.2022.100263_bib35 article-title: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.107.160192 – volume: 46 start-page: 730 year: 2016 ident: 10.1016/j.jlr.2022.100263_bib36 article-title: Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III publication-title: Eur. J. Clin. Invest. doi: 10.1111/eci.12657 – volume: 62 year: 2020 ident: 10.1016/j.jlr.2022.100263_bib10 article-title: Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease publication-title: J. Lipid Res. – volume: 40 start-page: 543 year: 1999 ident: 10.1016/j.jlr.2022.100263_bib9 article-title: Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)32459-7 – volume: 30 start-page: 239 year: 2010 ident: 10.1016/j.jlr.2022.100263_bib18 article-title: Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.109.197830 – volume: 6 start-page: 395 year: 2015 ident: 10.1016/j.jlr.2022.100263_bib20 article-title: Sitagliptin results in a decrease of truncated apolipoprotein C1 publication-title: Diabetes Ther. doi: 10.1007/s13300-015-0123-1 |
SSID | ssj0014461 |
Score | 2.4286816 |
Snippet | Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II')... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 100263 |
SubjectTerms | Apolipoprotein C-II Apolipoprotein C-III apolipoprotein posttranslational proteoforms Apolipoproteins Atherosclerosis cholesterol Female HDL Humans lipid metabolism lipid transport mass spectrometry proteomics race/ethnicity Triglycerides |
Title | Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis |
URI | https://dx.doi.org/10.1016/j.jlr.2022.100263 https://www.ncbi.nlm.nih.gov/pubmed/35952903 https://www.proquest.com/docview/2702194144 https://doaj.org/article/0cf7694d622b441b87f717b7082920e1 |
Volume | 63 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlPbSX0iZ9bJsEFUoPBVNblmXruFnyaAOllIbuTehl6pDIS7w55Nh_nhnJXppD00sw2MZY8uAZM99YM98Q8kFoqSusbrdO2ozbQmbGCJFxbxm3uHJkYoLsN3Fyxr8uq-Vfrb4wJyzRA6cX9zm3bS0kd4IxA67bNHULEYipsSaU5T4GPuDzpmBqXD-AIKeYeMIZq6tpPTNmdp1fIBEoY5F-VJR3PFIk7r_jmP4FPKMDOnpOno3Ikc6TxC_IIx-2yc48QNR8eUM_0pjLGX-Sb5Mni6mP2w758x0A8qWmkZGhR4w60L6lGtszrPp4tQsDXWRfqA4Oj3By5akeFecdxZ-1dJWmgUGdG2gXKEBHGut3s8P179BZijmJNzj3HFFlP4CYsO-Gl-Ts6PDn4iQbGy9klgu2zurGysL5pramcG3VVk1rha1w07nMPUfP11rtAKzVshGu0k1pC2c9tllnunxFtkIf_BtC61zLCiCoK7Gxic9lA-NLAB6yNYAlixnJp5ev7MhKjs0xLtSUfnauQF8K9aWSvmbk02bIKlFy3HfzAWp0cyOyaccLYGNqtDH1PxubET7ZgxqBSQIcMFV337PfT7ajQOe4EqOD768HhUWAheRgpjPyOhnVRkKslGYyL98-hOTvyFMUKCXF7ZKt9dW13wMUtTb75PH89Mev0_344cD-eFncAku_F1g |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+proteoforms+of+apolipoproteins+C-I+and+C-II+are+associated+with+plasma+lipids+in+the+Multi-Ethnic+Study+of+Atherosclerosis&rft.jtitle=Journal+of+lipid+research&rft.au=Koska%2C+Juraj&rft.au=Furtado%2C+Jeremy&rft.au=Hu%2C+Yueming&rft.au=Sinari%2C+Shripad&rft.date=2022-09-01&rft.issn=0022-2275&rft.volume=63&rft.issue=9&rft.spage=100263&rft_id=info:doi/10.1016%2Fj.jlr.2022.100263&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jlr_2022_100263 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2275&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2275&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2275&client=summon |